MiniMed Group, Inc. (MMED)
17.81
+0.32
(+1.83%)
USD |
NASDAQ |
Oct 19, 15:49
MiniMed Group Revenue (Quarterly) : 843.00M for July 31, 2026
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 843.00M |
| April 30, 2026 | 837.00M |
| January 31, 2026 | 790.00M |
| Date | Value |
|---|---|
| July 31, 2025 | 723.00M |
| April 30, 2025 | 724.00M |
| January 31, 2025 | 687.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (Quarterly) Benchmarks
| Abbott Laboratories | 12.59B |
| Baxter International, Inc. | 2.96B |
| Becton, Dickinson & Co. | 4.983B |
| Boston Scientific Corp. | 5.442B |
| DexCom, Inc. | 1.308B |
Revenue (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 843.00M |
| Enterprise Value | 4.770B |
| Gross Profit Margin (Quarterly) | 55.04% |
| Earnings Yield | -6.42% |
| Operating Earnings Yield | 7.98% |
| Normalized Earnings Yield | -0.7221 |